Vir Biotechnology, Inc. (VIR) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $68.56M | -7.6% |
| 2024 | $74.20M | -13.9% |
| 2023 | $86.18M | -94.7% |
| 2022 | $1.62B | +47.5% |
| 2021 | $1.10B | +1334.4% |
| 2020 | $76.37M | +843.9% |
| 2019 | $8.09M | -24.2% |
| 2018 | $10.67M | +293.9% |
| 2017 | $2.71M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $68.56M | -7.6% |
| 2024 | $74.20M | -13.9% |
| 2023 | $86.18M | -94.7% |
| 2022 | $1.62B | +47.5% |
| 2021 | $1.10B | +1334.4% |
| 2020 | $76.37M | +843.9% |
| 2019 | $8.09M | -24.2% |
| 2018 | $10.67M | +293.9% |
| 2017 | $2.71M | — |